U.S. Healthtech Stock News

DHT Holdings, Inc.'s ( NYSE:DHT ) price-to-earnings (or "P/E") ratio of 9.7x might make it look like a buy right now...

Some Lite Strategy, Inc. ( NASDAQ:LITS ) shareholders may be a little concerned to see that insider Alexander...

Trinity Biotech plc ( NASDAQ:TRIB ) shareholders would be excited to see that the share price has had a great month...

Insiders who acquired US$2.01m worth of Cable One, Inc.'s ( NYSE:CABO ) stock at an average price of US$171 in the past...

Those holding Pamt Corp. ( NASDAQ:PAMT ) shares would be relieved that the share price has rebounded 32% in the last...

Trinity Biotech plc ( NASDAQ:TRIB ) shares have had a really impressive month, gaining 54% after a shaky period...

Key Insights Given the large stake in the stock by institutions, Geospace Technologies' stock price might be vulnerable...

Some Helmerich & Payne, Inc. ( NYSE:HP ) shareholders may be a little concerned to see that the Chairman of the Board...

Assertio Holdings, Inc.'s ( NASDAQ:ASRT ) price-to-sales (or "P/S") ratio of 0.5x might make it look like a strong buy...

Many Willis Lease Finance Corporation ( NASDAQ:WLFC ) insiders ditched their stock over the past year, which may be of...

Those following along with The Cooper Companies, Inc. ( NASDAQ:COO ) will no doubt be intrigued by the recent purchase...

John B. Sanfilippo & Son, Inc.'s ( NASDAQ:JBSS ) price-to-earnings (or "P/E") ratio of 12.7x might make it look like a...

Graham Corporation ( NYSE:GHM ) shares have continued their recent momentum with a 29% gain in the last month alone...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Let's talk about the popular Crane Company ( NYSE:CR ). The company's shares received a lot of attention from a...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

We wouldn't blame Jabil Inc. ( NYSE:JBL ) shareholders if they were a little worried about the fact that Mark Mondello...

If you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 19x, you may...

Lionsgate Studios Corp. ( NYSE:LION ) shares have continued their recent momentum with a 26% gain in the last month...

If you are wondering whether Robinhood Markets has already had its big run or if there is still value on the table, you are not alone. That is exactly what we are going to unpack here. With the stock up 3.8% over the last week, 4.6% over the past month, and an eye catching 204.9% year to date, the market is clearly rethinking what Robinhood is worth. Part of that momentum has been fueled by steady product expansion, as Robinhood has pushed further into retirement accounts, credit products,...

In recent days, investors have been looking ahead to Prologis’ now-past Q4 2025 earnings release as a key checkpoint following recently reported strong Q3 operational results and high portfolio occupancy. This renewed focus on near-term performance underscores how closely the market is watching whether Prologis can sustain leasing momentum and operational strength in its logistics portfolio. We’ll now examine how anticipation around Prologis’ Q4 earnings and its high occupancy levels feeds...

Elanco Animal Health (ELAN) just checked two important boxes for investors, pairing a conditional FDA green light for its Credelio Quattro-CA1 parasite treatment with a wave of upbeat Wall Street commentary. See our latest analysis for Elanco Animal Health. The conditional approval lands after a powerful run, with an 84 percent year to date share price return and an 87 percent one year total shareholder return. This signals momentum that still looks more like a turnaround than a trade. If...

Medtronic (MDT) has quietly outperformed the broader healthcare space this year, and its latest move in refining its device portfolio is giving investors a fresh reason to revisit the stock’s long term trajectory. See our latest analysis for Medtronic. That steady portfolio work is backing up what the market has already started to price in, with a 21.5% year to date share price return and a 23.5% one year total shareholder return suggesting momentum is still quietly building rather than...